Late stent malapposition with marked positive vascular remodeling observed only at the site of drug-eluting stents after multivessel coronary stenting

Heart and Vessels

Volumn 24, Issue 4, 2009, Pages 308-312

  Watanabe, Yusuke ^a   Asano, Ryuta ^a   Hata, Noriko ^a   Inoue, Kanki ^a   Takamisawa, Itaru ^a   Seki, Atsushi ^a   Aikawa, Masaru ^a   Tobaru, Tetsuya ^a   Misu, Kazuhiko ^a   Iguchi, Nobuo ^a   Nagayama, Masatoshi ^a   Watanabe, Hiroyuki ^a   Takayama, Morimasa ^a   Umemura, Jun ^a   Sumiyoshi, Tetsuya ^a  

^a SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Coronary artery disease; Drug eluting stent; Late stent malapposition; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; RAPAMYCIN; TICLOPIDINE;

AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CASE REPORT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMALE; FOREIGN BODY; HEART VENTRICLE REMODELING; HUMAN; INTRAVASCULAR ULTRASOUND; LATE STENT MALAPPOSITION; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; THORAX PAIN;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERSENSITIVITY; METALS; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 68249147568     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1124-z     Document Type: Article

References (16)

1. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ (2004) Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 109:881-886
2. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC (2002) Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106:798-803
3. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115:2426-2434
4. Mintz GS, Weissman NJ, Fitzgerald PJ (2001) Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation 104:1320-1325
5. Shah VM, Mintz GS, Apple S, Weissman NJ (2002) Background incidence of late malapposition after bare-metal stent implantation. Circulation 106:1753-1755
6. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A (2005) Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation 111:900-905
7. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ (2006) Late stent malapposition after drugeluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 113:414-419
8. Shah VM, Mintz GS, Apple S, Weissman NJ (2002) Background incidence of late malapposition after bare-metal stent implantation. Circulation 106:1753-1755
9. Mintz GS, Shah VM, Weissman NJ (2003) Regional remodeling as the cause of late stent malapposition. Circulation 107:2660-2663
10. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109: 701-705
11. Marx SO, Marks AR (2001) Bench to bedside: The development of rapamycin and its application to stent restenosis. Circulation 104:852-855
12. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Yilimaz H, Cam N (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82
13. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD (2006) Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47:175-181
14. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Kutcher M, Wong SC, Strickland W, Mooney M, Russell ME, Ellis SG, Stone GW (2005) Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1201-1205
15. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, Morice MC, Ligthart JM, de Feyter PJ (2003) Long-term followup of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 108:2747-2750
16. Azarbal B, Currier JW (2006) Allergic reactions after the implantation of drug-eluting stents J Am Coll Cardiol 47:182-183